IP Verse

Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xv - EP2325643

EP2325643

BECTON DICKINSON INFUSION THERAPY SYSTEMS
Application Number
EP10016031A
Filing Date
Oct 10, 2006
Status
Revoked
Jun 20, 2024
Grant Date
Dec 1, 2021
External Links
Slate, Register, Google Patents

Bibliography

The patent EP2325643B1 was granted to Becton Dickinson Infusion Therapy Systems on Dec 1, 2021 following the initial filing on Oct 10, 2006 under the application number EP10016031A . The current legal status of the patent is Revoked.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BECKMAN COULTERAug 31, 2022ADMISSIBLE

Patent Citations New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePatent NumberPatent Link
DESCRIPTIONWO2002CA00824-
DESCRIPTIONEP0543942
DESCRIPTIONUS4683195
DESCRIPTIONUS4683202
DESCRIPTIONUS5780610
DESCRIPTIONUS5866366
DESCRIPTIONUS6090592
DESCRIPTIONUS6117635
DESCRIPTIONUS6117986
DESCRIPTIONUS6156507
DESCRIPTIONWO0123604
OPPOSITIONEP0887424
OPPOSITIONEP1529847
OPPOSITIONUS6156507
OPPOSITIONWO02099034
SEARCHUS2005019893

Non-Patent Literature (NPL) Citations New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- AL-SOUD; RADSTROM, APPL. ENVIRON. MICROBIOL., (1998), vol. 64, pages 3748 - 3753-
DESCRIPTION- AL-SOUD; RADSTROM, J. CLIN. MICROBIOL., (2002), vol. 38, pages 4463 - 4470-
DESCRIPTION- AMHEIM, C&EN, (1990), pages 36 - 47-
DESCRIPTION- BARRINGER, GENE, (1990), vol. 89, page 117-
DESCRIPTION- BERGER, METHODS ENZYMOL., (1987), vol. 152, pages 307 - 316-
DESCRIPTION- CHAKRABARTI; SCHUTT, BIOTECHNIQUES, (2002), vol. 32, pages 866 - 874-
DESCRIPTION- C. R. NEWTON ET AL., PCR, SPRINGER-VERLAG, (1997), page 24-
DESCRIPTION- EGHOLM ET AL., NATURE, (1993), vol. 365, pages 566 - 568-
DESCRIPTION- ELGHANIAN ET AL., SCIENCE, (1997), vol. 277, pages 1078 - 1081-
DESCRIPTION- FLORES ET AL., BIOTECHNIQUES, (1992), vol. 13, pages 203 - 205-
DESCRIPTION- GUATELLI, PROC. NATL. ACAD. SCI. USA, (1990), vol. 87, page 1874-
DESCRIPTION- HIRAMATSU ET AL., J. INFECT. CHEMOTHER., (1996), vol. 2, pages 117 - 129-
DESCRIPTION- HIRAMATSU ET AL., MICROBIOL. IMMUNOL., (1992), vol. 36, pages 445 - 453-
DESCRIPTION- HULETSKY ET AL., J CLIN. MICROBIOL., (2004), vol. 42, pages 1875 - 1884-
DESCRIPTION- HULETSKY ET AL., J. CLIN. MICROBIOL., (2004), vol. 42, pages 1875 - 1884-
DESCRIPTION- ITO, ANTIMICROB AGENTS CHEMOTHER., (2004), vol. 48, pages 2637 - 2651-
DESCRIPTION- ITO, ANTIMICROB. AGENTS CHEMOTHER., (2004), vol. 48, pages 2637 - 2651-
DESCRIPTION- ITO ET AL., ANTIMICROB. AGENTS CHEMOTHER., (1999), vol. 43, pages 1449 - 1458-
DESCRIPTION- ITO ET AL., ANTIMICROB. AGENTS CHEMOTHER., (2001), vol. 45, pages 1323 - 1336-
DESCRIPTION- ITO ET AL., ANTIMICROB AGENTS CHEMOTHER., (2004), vol. 48, pages 2637 - 2651-
DESCRIPTION- ITO ET AL., ANTIMICROB. AGENTS. CHEMOTHER., (2004), vol. 48, pages 2637 - 2651-
DESCRIPTION- KATAYAMA ET AL., ANTIMICROB. AGENTS CHEMOTHER., (2000), vol. 44, pages 1549 - 1555-
DESCRIPTION- KOSKIN ET AL., TETRAHEDRON, (1998), vol. 54, pages 3607 - 3630-
DESCRIPTION- KRAMER FR., NAT BIOTECHNOL, (1996), vol. 3, pages 303 - 8-
DESCRIPTION- KWOH, PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, page 1173-
DESCRIPTION- LANDEGREN, SCIENCE, (1988), vol. 241, page 1077-
DESCRIPTION- LEACH ET AL., J. AM. CHEM. SOC., (1992), vol. 114, pages 3675 - 3683-
DESCRIPTION- LEWIN, Genes IV, JOHN WILEY & SONS, (1989), vol. 4-
DESCRIPTION- LOMELL J, CLIN. CHEM., (1989), vol. 35, page 1826-
DESCRIPTION- MA, ANTIMICROB. AGENTS CHEMOTHER., (2002), vol. 46, pages 1147 - 1152-
DESCRIPTION- MA ET AL., ANTIMICROB. AGENTS CHEMOTHER., (2002), vol. 46, pages 1147 - 1152-
DESCRIPTION- MANTSCH ET AL., BIOCHEM., (1975), vol. 14, pages 5593 - 5601-
DESCRIPTION- MARTINEAU ET AL., ANTIMICROB. AGENTS CHEMOTHER., (2000), vol. 44, pages 231 - 238-
DESCRIPTION- MURAKAMI ET AL., J. CLIN. MICROBIOL., (1991), vol. 29, pages 2240 - 2244-
DESCRIPTION- NICHOLS ET AL., NATURE, (1994), vol. 369, pages 492 - 493-
DESCRIPTION- OLIVEIRA; DE LENCASTRE, ANTIMICROB. AGENTS CHEMOTHER., (2002), vol. 46, pages 2155 - 2161-
DESCRIPTION- OLIVEIRA ET AL., LANCET INFECT DIS., (2002), vol. 2, pages 180 - 9-
DESCRIPTION- OLIVEIRA ET AL., MICROB. DRUG RESIST., (2001), vol. 7, pages 349 - 360-
DESCRIPTION- OLIVEIRA, MICROB. DRUG RESIST., (2001), vol. 7, pages 349 - 360-
DESCRIPTION- PICCIRILLI ET AL., NATURE, (1990), vol. 343, pages 33 - 37-
DESCRIPTION- SAITO ET AL., J. CLIN. MICROBIOL., (1995), vol. 33, pages 2498 - 2500-
DESCRIPTION- SOOKNANAN, BIOTECHNOLOGY, (1995), vol. 13, pages 563 - 564-
DESCRIPTION- SUZUKI ET AL., ANTIMICROB. AGENTS. CHEMOTHER., (1992), vol. 36, pages 429 - 434-
DESCRIPTION- SWITZER ET AL., BIOCHEMISTRY, (1993), vol. 32, pages 10489 - 10496-
DESCRIPTION- THEWELL, NUCL. ACIDS RES., (2000), vol. 28, page 3752-
DESCRIPTION- TOR ET AL., J. AM. CHEM. SOC., (1993), vol. 115, pages 4461 - 4467-
DESCRIPTION- TYAGI ET AL., NAT. BIOTECH., (1996), vol. 14, pages 303 - 308-
DESCRIPTION- UBUKATA ET AL., ANTIMICROB. AGENTS CHEMOTHER., (1990), vol. 34, pages 170 - 172-
DESCRIPTION- UBUKATA ET AL., J. CLIN. MICROBIOL., (1992), vol. 30, pages 1728 - 1733-
DESCRIPTION- VAN BRUNT, BIOTECHNOLOGY, (1990), vol. 8, pages 291 - 294-
DESCRIPTION- WILSON, APPL. ENVIRON. MICROBIOL., (1997), vol. 63, pages 3741 - 3751-
DESCRIPTION- WU, GENE, (1989), vol. 4, page 560-
DESCRIPTION- WU, GENOMICS, (1989), vol. 4, page 560-
OPPOSITION- Anonymous, "Class 2 Device Recall BD GeneOhm MRSA", FDA, (20081031), pages 1 - 3, XP055960583-
OPPOSITION- Anonymous, "Journal of Clinical Microbiology Instructions to Authors", American society for Microbiology, (20040000), pages 1 - 18, XP055960549-
OPPOSITION- COOKSON et al., "Evaluation of molecular typing methods in characterizing a European collection of epidemic methicillin-resistant Staphylococcus aureus strains: the HARMONY collection", Journal of Clinical Microbiology, (20070600), vol. 45, no. 6, pages 1830 - 1837, XP055915391-
OPPOSITION- ITO et al., "Insight on antibiotic resistance of staphylococcus aureus from its whole genome: genomic island SCC", Drug Resistance Updates, (20030000), vol. 6, pages 41 - 52, XP055960454-
OPPOSITION- HAGEN et al., "Development of a real-time PCR assay for identification of methicillin-resistant staphylococcus aureus from clinical samples", International Journal of Medical Microbiology, (20050000), vol. 295, pages 77 - 86, XP027820869
OPPOSITION- Hiramatsu K; Katayama Y; Yuzawa H; Ito T, Int. J. Med. Microbiol., (20020000), vol. 292, pages 67 - 74, XP004960045
OPPOSITION- OLIVEIRA et al., "The evolution of pandemic clones of methicillin-resistant staphylococcus aureus: identification of two ancestral genetic backgrounds and the associated mec elements", Microbial Drug Resistance, (20010000), vol. 7, no. 4, pages 349 - 361, XP009004903
OPPOSITION- CUNY et al., "PCR for the identification of methicillin-resistant staphylococcus aureus (MRSA) strains using a single primer pair specific for SCCmec elements and the neighbouring chromosome-borne orfx", Clin Microbiol Infect, (20050000), vol. 11, pages 834 - 837, XP002451789
OPPOSITION- Anne-Merethe Hanssen; Johanna U Ericson Sollid, "SCC mec in staphylococci: genes on the move", FEMS Immunol Med Microbiol, (20050919), vol. 46, pages 8 - 20, XP055659855
OPPOSITION- ITO et al., "Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus", Antimicrobial Agents and Chemotherapy, (20010500), pages 1323 - 1336, XP002238384
OPPOSITION- ITO et al., "Novel Type V Staphylococcal Cassette Chromosome mec Driven by a Novel Cassette Chromosome Recombinase, ccrC", Antimicrobial Agents and Chemotherapy, (20040700), pages 2637 - 2651, XP002451790
OPPOSITION- Thanh T Luong, "Type 1 capsule genes of staphylococcus aureus are carried in a staphylococcal cassette chromosome genetic element", J. Bacteriol., (20020000), vol. 184, no. 13, pages 3623 - 3629, XP055284393
OPPOSITION- ZHANG et al., "Comparison of Two Versions of the IDI-MRSA Assay Using Charcoal Swabs for Prospective Nasal and Nonnasal Surveillance Samples", Journal of Clinical Microbiology, (20070700), pages 2278 - 2280, XP055659911
OPPOSITION- HULETSKY et al., "New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci", Journal of Clinical Microbiology, (20040501), vol. 42, no. 5, pages 1878 - 1884, XP003003502
SEARCH- HAGEN R M ET AL, "Development of a real-time PCR assay for rapid identification of methicillin-resistant Staphylococcus aureus from clinical samples", INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, URBAN UND FISCHER, DE, vol. 295, no. 2, ISSN 1438-4221, (20050601), pages 77 - 86, (20050601), XP025339023 [A] 1-23 * page 78-80; Materials and methods; figure 1 *
SEARCH- HULETSKY A ET AL, "New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci", JOURNAL OF CLINICAL MICROBIOLOGY, WASHINGTON, DC, US, (20040501), vol. 42, no. 5, ISSN 0095-1137, pages 1875 - 1884, XP003003502 [AD] 1-23 * page 1879, table 3 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents